Huadong Medicine Co., Ltd.: Diabetes Mellitus, Type 2 trials
The registry lists 10 Diabetes Mellitus, Type 2 studies with Huadong Medicine Co., Ltd. as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 2Phase 3 5Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNot yet recruitingNCT07417306Phase 3
- A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneRecruitingNCT07394114Phase 3
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
- Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07193459Phase 3
- Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNot yet recruitingNCT07116928Phase 4
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminRecruitingNCT07109700Phase 2
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07082114Phase 3
- Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 DiabetesCompletedNCT06739044Phase 3
- Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.CompletedNCT06634927Phase 1
- To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusCompletedNCT06481085Phase 2